title: The use of zoledronic acid in men receiving androgen deprivation therapy for prostate cancer with severe osteopenia or osteoporosis.
authors.affiliation: Edward Hines Jr VA Hospital, Hines, Illinois, USA. campbes3@ccf.org
authors.forename: Steven C
authors.initials: SC
authors.lastname: Campbell
authors.forename: Nirmala
authors.initials: N
authors.lastname: Bhoopalam
authors.forename: Thomas E
authors.initials: TE
authors.lastname: Moritz
authors.forename: Mona
authors.initials: M
authors.lastname: Pandya
authors.forename: Padmini
authors.initials: P
authors.lastname: Iyer
authors.forename: Peter
authors.initials: P
authors.lastname: Vanveldhuizen
authors.forename: Nancy K
authors.initials: NK
authors.lastname: Ellis
authors.forename: Lizy
authors.initials: L
authors.lastname: Thottapurathu
authors.forename: Harinder
authors.initials: H
authors.lastname: Garewal
authors.forename: Stuart R
authors.initials: SR
authors.lastname: Warren
authors.forename: Nicholas
authors.initials: N
authors.lastname: Friedman
authors.forename: Domenic J
authors.initials: DJ
authors.lastname: Reda
mesh_terms: D000368:Aged; D000726:Androgen Antagonists / Q000627:therapeutic use; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001851:Bone Diseases, Metabolic / Q000209:etiology / Q000517:prevention & control*; D004164:Diphosphonates / Q000627:therapeutic use*; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008297:Male; D009919:Orchiectomy; D010024:Osteoporosis / Q000209:etiology / Q000517:prevention & control*; D011471:Prostatic Neoplasms / Q000628:therapy*; D012720:Severity of Illness Index; D000077211:Zoledronic Acid
chemical_list: D000726:Androgen Antagonists; D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D007987:Gonadotropin-Releasing Hormone; D000077211:Zoledronic Acid